Clinical Trial

A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This was a multicenter, open-label, phase I study to evaluate the safety, tolerability, radiation dosimetry and efficacy of \[177Lu\] Lu-PSMA-XT injection in patients with metastatic prostate cancer .
Trial Details
NCT Number NCT07096128
Lead Sponsor Jinming Zhang
Collaborators: Sinotau Pharmaceutical Group
Conditions mCRPC
Enrollment 36 participants
Start Date 2024-08-20
Primary Completion 2026-05-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-31